» Articles » PMID: 10375558

IL-12 and IFN-gamma in Host Defense Against Mycobacteria and Salmonella in Mice and Men

Overview
Publisher Elsevier
Date 1999 Jun 22
PMID 10375558
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

The development of gene-knockout mice and the identification of gene-deficient humans have improved our understanding of the role of IL-12 and IFN-gamma in host defense. Comparison of experimental and natural infections has shown that animals and humans genetically deficient in immunity mediated by IL-12 or IFN-gamma are highly susceptible to mycobacteria and salmonella. Impaired secretion of, or response to, IFN-gamma is the common pathogenic mechanism that accounts for impaired granuloma formation and uncontrolled growth of bacteria within macrophages. The axis formed between IL-12 and IFN-gamma is essential for protective immunity against mycobacteria and salmonella in mice and men.

Citing Articles

Acute Ascaris infection impairs the effector functions of natural killer cells in single and Salmonella co-infected pigs.

Mugo R, Oser L, Midha A, Adjah J, Kundik A, Laubschat A Sci Rep. 2024; 14(1):14586.

PMID: 38918457 PMC: 11199589. DOI: 10.1038/s41598-024-64497-4.


Mycobacterium tuberculosis PE_PGRS45 (Rv2615c) Promotes Recombinant Mycobacteria Intracellular Survival via Regulation of Innate Immunity, and Inhibition of Cell Apoptosis.

Xu T, Wang C, Li M, Wei J, He Z, Qian Z J Microbiol. 2024; 62(1):49-62.

PMID: 38337112 DOI: 10.1007/s12275-023-00101-0.


Role of Cyclin D1b in Inducing Macrophages Toward a Tumor-associated Macrophage-like Phenotype in Murine Breast Cancer.

Xiang L, Rao Q, He B, Guo X, Xu Y, Luo B Curr Med Sci. 2023; 43(4):655-667.

PMID: 37391677 DOI: 10.1007/s11596-023-2762-1.


Targeting IL-23 for IBD: Rationale and Progress to Date.

Vuyyuru S, Shackelton L, Hanzel J, Ma C, Jairath V, Feagan B Drugs. 2023; 83(10):873-891.

PMID: 37266801 DOI: 10.1007/s40265-023-01882-9.


SLAMF8 Downregulates Mouse Macrophage Microbicidal Mechanisms PI3K Pathways.

Romero-Pinedo S, Barros D, Ruiz-Magana M, Maganto-Garcia E, Moreno de Lara L, Abadia-Molina F Front Immunol. 2022; 13:910112.

PMID: 35837407 PMC: 9273976. DOI: 10.3389/fimmu.2022.910112.